Завершено
Фаза III
Здоровые добровольцы
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector); Placebo · «КанСино Байолоджикс Инк.» (CanSino Biologics Inc.)
A Global Multicenter, Randomized, Double-blind, Placebo -Controlled, Adaptive Designed Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of Ad5-nCoV in Adults 18 Years of Age and Older